The multicenter, phase III trial, DREAMseq showed a remarkable 20% advantage in the two-year…
Radformation Inc and Videra Surgical are integrating Videra Surgical’s VeraForm…
UTHealth Houston researchers report in JAMA Network Open that US populations more vulnerable…
Research published in The Journal of Nuclear Medicine reports a new PET radiotracer…
The US FDA has accepted Blue Earth Diagnostics’ New Drug Application…
The discovery that one specific lupus antibody, known as 3E10, can penetrate cancer cells…
A new multidisciplinary team examining radiation therapy combined with immunotherapy will be…
Telix Pharmaceuticals Limited reported the IPAX-1 Phase I/II study of TLX101 therapy (4-L-[…
A joint venture by The University of Texas MD Anderson Cancer Center and Radiopharm…
The US FDA has cleared the OptaBlate bone tumor ablation system from Stryker, expanding the…
